National security

Skydio Enters Final Phase of U.S. Army’s Short Range Reconnaissance Tranche 2 Program

Retrieved on: 
Wednesday, January 10, 2024

Skydio , the leading U.S. drone manufacturer and world leader in autonomous flight technology, today announced it has entered into the final phase of the U.S. Army’s Short Range Reconnaissance (SRR) tranche 2 program, where it intends to deliver the powerful Skydio X10D small UAS (sUAS), the next generation of autonomous drone technology.

Key Points: 
  • Skydio , the leading U.S. drone manufacturer and world leader in autonomous flight technology, today announced it has entered into the final phase of the U.S. Army’s Short Range Reconnaissance (SRR) tranche 2 program, where it intends to deliver the powerful Skydio X10D small UAS (sUAS), the next generation of autonomous drone technology.
  • Skydio remains the solution provider of record for the U.S. Army’s Short Range Reconnaissance program, which it won in November 2021 .
  • The Skydio X10 platform combines new, cutting-edge data capture cameras, unparalleled autonomy, and versatile hardware to serve a range of industries, including defense, public safety, and utilities.
  • The SRR program is designed to equip soldiers with a rapidly deployable small UAS solution to conduct reconnaissance and surveillance (R&S) activities.

Claroty Welcomes Former U.S. National Cyber Director Chris Inglis to Advisory Board

Retrieved on: 
Wednesday, January 10, 2024

NEW YORK, Jan. 10, 2024 /PRNewswire/ -- Claroty, the cyber-physical systems protection company, today announced the appointment of Chris Inglis, former U.S. National Cyber Director, to its advisory board. With an illustrious career spanning both military and civilian spheres, Inglis brings unparalleled expertise in cybersecurity and national defense to help drive forward the company's mission to secure the world's critical infrastructure.

Key Points: 
  • NEW YORK, Jan. 10, 2024 /PRNewswire/ -- Claroty , the cyber-physical systems protection company, today announced the appointment of Chris Inglis, former U.S. National Cyber Director, to its advisory board.
  • He also serves as a senior advisor to Hakluyt and Company and is a valued member of the Huntington Bancshares Board.
  • His dedication to advancing cybersecurity is further evidenced by his role on the U.S. Department of Homeland Security Cybersecurity Advisory Council.
  • From 2021 to 2023, Inglis served as the inaugural Senate-confirmed U.S. National Cyber Director in the White House.

Muon Space Selected by AFWERX for SBIR Phase I Contract

Retrieved on: 
Tuesday, January 9, 2024

MOUNTAIN VIEW, Calif., Jan. 9, 2024 /PRNewswire/ -- Muon Space, a LEO satellite constellation company revolutionizing the way Earth is monitored from space, has been selected by AFWERX for a SBIR Phase I contract focused on weather intelligence, surveillance and reconnaissance (ISR) and operational mission planning. Muon Space will perform a feasibility study to determine the benefit of modifying its multispectral Electro-Optical/Infrared (EO/IR) instrument to support the Department of Defense's (DoD) cloud characterization observation capability.

Key Points: 
  • MOUNTAIN VIEW, Calif., Jan. 9, 2024 /PRNewswire/ -- Muon Space , a LEO satellite constellation company revolutionizing the way Earth is monitored from space, has been selected by AFWERX for a SBIR Phase I contract focused on weather intelligence, surveillance and reconnaissance (ISR) and operational mission planning.
  • Muon Space will perform a feasibility study to determine the benefit of modifying its multispectral Electro-Optical/Infrared (EO/IR) instrument to support the Department of Defense's (DoD) cloud characterization observation capability.
  • Muon Space is developing an EO/IR constellation solution that offers a commercial path to fill these gaps and ensure mission-critical data delivery.
  • Announced in July , this is an expansion in scope to the original contract awarded to Muon Space in September 2022 to develop a space-based prototype for global weather sensing.

Pentagon to Deliver Report on Domestic Processing of Seafloor Nodules by March 1 as President Biden Signs NDAA

Retrieved on: 
Wednesday, January 3, 2024

Under the National Defense Authorization Act (FY24) now signed into law by President Biden, the House Armed Services Committee directs the Assistant Secretary of Defense for Industrial Base Policy to submit a report assessing the domestic processing of seafloor polymetallic nodules by March 1, 2024.

Key Points: 
  • Under the National Defense Authorization Act (FY24) now signed into law by President Biden, the House Armed Services Committee directs the Assistant Secretary of Defense for Industrial Base Policy to submit a report assessing the domestic processing of seafloor polymetallic nodules by March 1, 2024.
  • The news comes as American and allied auto and battery makers struggle to secure supplies of critical battery metals that comply with guidelines for incentives under the Inflation Reduction Act.
  • NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), an explorer of the world’s largest estimated undeveloped source of critical battery metals, today welcomed the passage of the 2024 National Defense Authorization Act (NDAA) into law and the inclusion of provisions directing the Department of Defense to submit a report to the House Armed Services Committee assessing the domestic processing of seafloor polymetallic nodules by March 1, 2024.
  • In a letter to the Assistant Secretary of Defense for Industrial Base Policy, Laura D. Taylor-Kale, the Members wrote: “The applicant seems to have the ability to produce battery-grade materials at commercial facilities in North America at pilot scale.

Horizon Aircraft Announces Board of Directors for Post-Merger Public Company

Retrieved on: 
Tuesday, January 2, 2024

TORONTO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Robinson Aircraft Ltd., doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), a hybrid electric Vertical TakeOff and Landing (“eVTOL”) aircraft developer, which previously announced that it would become a public company via a business combination with publicly-traded special purpose acquisition company, Pono Capital Three, Inc. (“Pono”)(Nasdaq: PTHR), today announced its Board of Directors, effective at the closing of its business combination.

Key Points: 
  • ~ Board Announced in Anticipation of January 2024 Merger Between Horizon Aircraft and Pono Capital Three, Inc. ~
    TORONTO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Robinson Aircraft Ltd., doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), a hybrid electric Vertical TakeOff and Landing (“eVTOL”) aircraft developer, which previously announced that it would become a public company via a business combination with publicly-traded special purpose acquisition company, Pono Capital Three, Inc. (“Pono”)(Nasdaq: PTHR), today announced its Board of Directors, effective at the closing of its business combination.
  • The post-merger Horizon Aircraft Board of Directors will be led by Brandon Robinson, Founder and Chief Executive Officer of Horizon and is comprised of five (5) directors that bring considerable field operations, corporate governance and executive management experience across the aviation and technology sectors.
  • Brandon Robinson, Founder, Chief Executive Officer and Chairman of Horizon Aircraft commented, “We are grateful to have inspired both experienced public and private company executives to help shape the trajectory of Horizon Aircraft.
  • I look forward to working in partnership with this elite group to continue the development of our groundbreaking technology.”
    The composition of the post-merger Horizon Aircraft Board of Directors includes:
    Brandon is the co-founder and CEO of Horizon Aircraft.

Red Cat Endorses Passing of the American Security Drone Act

Retrieved on: 
Tuesday, December 26, 2023

SAN JUAN, Puerto Rico, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government and commercial operations, endorses the passing of the American Security Drone Act (ASDA) as an important legislation package that benefits the federal government, domestic drone businesses, and national security.

Key Points: 
  • SAN JUAN, Puerto Rico, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government and commercial operations, endorses the passing of the American Security Drone Act (ASDA) as an important legislation package that benefits the federal government, domestic drone businesses, and national security.
  • Introduced in November 2023, the bipartisan act prevents the federal government from procuring drones from countries that are deemed security threats, such as China.
  • “The passing of the American Security Drone Act is a major milestone for domestic drone companies and also for protecting the U.S. and our allies,” stated Jeff Thompson, Founder and CEO of Red Cat.
  • This act will level the playing field for American manufacturing against our greatest geopolitical rival,” stated Brendan Stewart, VP, Regulatory Affairs at Red Cat.

Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine

Retrieved on: 
Monday, December 18, 2023

“The formulation development of our novel lyophilized formulation of Bucillamine at the University of Waterloo is near complete, and we are now entering into the next phase of our product development cycle and preparing for a clinical trial,” said Michael Frank, CEO of Revive.

Key Points: 
  • “The formulation development of our novel lyophilized formulation of Bucillamine at the University of Waterloo is near complete, and we are now entering into the next phase of our product development cycle and preparing for a clinical trial,” said Michael Frank, CEO of Revive.
  • The collaboration between Revive and AMS will support the technology transfer of the lyophilized formulation of Bucillamine from the University of Waterloo (“UW”) to AMS.
  • After completing the technology transfer, AMS will begin the development and clinical trial manufacturing of lyophilized Bucillamine under GMP.
  • The Company expects to have its novel lyophilized Bucillamine ready for clinical evaluation in 2024.

Odysight.ai CEO Yehu Ofer Elected as Member of the International Board of the Weizmann Institute

Retrieved on: 
Wednesday, November 22, 2023

Mr. Ofer's appointment to this role reflects a significant recognition from one of Israel's top scientific and technological research organizations.

Key Points: 
  • Mr. Ofer's appointment to this role reflects a significant recognition from one of Israel's top scientific and technological research organizations.
  • This recognition exemplifies Mr. Ofer's exceptional and outstanding reputation within leading technological defense and commercial organizations in Israel and abroad.
  • Yehu Ofer assumed the position of CEO of Odysight.ai on October 18, 2022.
  • "The Board of Directors and I proudly congratulate Mr. Yehu Ofer on his election to the International Board of the Weizmann Institute", said Prof. Benad Goldwasser, Chairman of the Board of Odysight.ai.

Transformative Partnership Between Kratos Defense & Rocket Support Solutions and ReLogic Research Created

Retrieved on: 
Wednesday, November 22, 2023

HUNTSVILLE, Ala., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Kratos Defense & Rocket Support Solutions, Inc. (Kratos), a subsidiary of Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a Technology Company in the Defense, National Security and Global Markets, and ReLogic Research, Inc., are proud to announce the formation of Atreus Technologies, LLC, a Small Business Association Mentor Protégé Program joint venture.

Key Points: 
  • HUNTSVILLE, Ala., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Kratos Defense & Rocket Support Solutions, Inc. (Kratos), a subsidiary of Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a Technology Company in the Defense, National Security and Global Markets, and ReLogic Research, Inc., are proud to announce the formation of Atreus Technologies, LLC, a Small Business Association Mentor Protégé Program joint venture.
  • Atreus, the son of Kratos, was the inspiration for the name chosen for this strategic partnership that embodies the formidable strength, unwavering determination and forward-thinking innovation that both Kratos and ReLogic Research are renowned for within their respective fields.
  • At Kratos, affordability is a technology, and Kratos’ leading technology approaches also reduce program and initiative cost, risk and schedule.
  • Charles Farmer, Senior Vice President at Kratos, shared his enthusiasm, stating, “I am incredibly excited to embark on this mentor protégé joint venture with ReLogic Research.

Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development

Retrieved on: 
Tuesday, November 21, 2023

TORONTO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, provides an update on the development of a next generation lyophilized formulation of Bucillamine.

Key Points: 
  • TORONTO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, provides an update on the development of a next generation lyophilized formulation of Bucillamine.
  • Under an agreement with the University of Waterloo, formulation development work is ongoing and is expected to be completed by the end of the year.
  • Specifically, the novel Bucillamine formulation could support the continuation of the research project the Company has with the Defence R&D Canada - Suffield, an agency of the Canadian Department of National Defence, to evaluate Bucillamine as a potential treatment for nerve agent exposure.
  • The Company expects to have its novel lyophilized formulation of Bucillamine ready for production with a contract development manufacturing organization for clinical evaluation in 2024.